The creation, maintenance, processing, and/or review of laboratory data was inadequate.
Inspection Record
Aktinos Pharma Pvt Limited — Health Canada Inspection Findings
View the regulator's official source The source document is always the basis for judgement.
Findings
The quality control department did not appropriately approve, assess, and/or document the reprocessing and/or reworking of a lot and/or batch.
The premises were not designed, constructed, operated, and/or maintained to prevent contamination. The labelling of outlets for liquids and/or gases was inadequate.
The identity testing of primary packaging materials once they were received on the premises by a person that packages the drugs was inadequate.
The assessment, documentation, and/or procedures for considering the resale of returned drugs were inadequate.
The availability, content and/or maintenance of the quality agreements between the supplier, fabricator, tester, packager, labeller, distributor, importer, and/or wholesaler was inadequate.
The temperature and/or humidity control was inadequate.
The investigation, handling, and/or reporting of test results that were out-of-specification was inadequate.
The implementation, effectiveness, and/or validation of the cleaning procedures was inadequate for preventing unsanitary conditions.
About this record
Extracted automatically from the document of the Health Canada inspection on 2024-09-09. The source is available at the link above.
This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.
Translation and classification are automated and may differ in nuance from the source.
